Literature DB >> 11034939

Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.

J B Muhlestein1, B D Horne, J F Carlquist, T E Madsen, T L Bair, R R Pearson, J L Anderson.   

Abstract

BACKGROUND: The role of inflammation in coronary artery disease (CAD) is being increasingly recognized. Markers of inflammation (eg, C-reactive protein [CRP]) and infection (eg, seropositivity to Chlamydia pneumoniae, cytomegalovirus [CMV], and Helicobacter pylori) have been proposed as risk factors for CAD, but these associations require further evaluation. METHODS AND
RESULTS: We prospectively tested whether CRP levels and IgG seropositivity to C pneumoniae, CMV, and H pylori are predictors of subsequent mortality in 985 consecutive patients with angiographically demonstrated CAD (stenosis >/=70%). Patients were followed for an average of 2.7 years (range 1.5 to 4.0 years). Patients averaged 65 years of age; 77% were men; and 110 (11.2%) died during follow-up. CRP levels were significantly elevated in nonsurvivors compared with survivors (mean CRP 3.1 mg/dL versus 1.5 mg/dL, P:=0.003). After controlling for all known baseline variables, the 2nd and 3rd tertiles of CRP compared with the 1st produced a Cox hazard ratio (HR) for mortality of 2.4 (P:=0.001). Of the 3 infectious markers tested, only seropositivity to CMV (HR=1.9, P:<0.05) was predictive of mortality. The majority of mortality risk associated with elevated CRP or CMV seropositivity occurred when both risk factors were present (P: for trend <0.0001). Other independent predictors of increased risk of mortality were age (HR=1.07 per year, P:<0.0001), left ventricular ejection fraction (HR=0.97 per percent, P:<0.0001), and diabetes mellitus (HR=1.7, P:=0.02).
CONCLUSIONS: CMV seropositivity and elevated CRP, especially when in combination, are strong, independent predictors of mortality in patients with CAD. This suggests an interesting hypothesis that a chronic, smoldering infection (CMV) might have the capacity to accelerate the atherothrombotic process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034939     DOI: 10.1161/01.cir.102.16.1917

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 2.  The role of cytomegalovirus in angiogenesis.

Authors:  Patrizia Caposio; Susan L Orloff; Daniel N Streblow
Journal:  Virus Res       Date:  2010-10-01       Impact factor: 3.303

3.  Cytomegalovirus infection enhances the immune response to influenza.

Authors:  David Furman; Vladimir Jojic; Shalini Sharma; Shai S Shen-Orr; Cesar J L Angel; Suna Onengut-Gumuscu; Brian A Kidd; Holden T Maecker; Patrick Concannon; Cornelia L Dekker; Paul G Thomas; Mark M Davis
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

4.  Human cytomegalovirus UL38 protein blocks apoptosis.

Authors:  Scott Terhune; Emi Torigoi; Nathaniel Moorman; Maria Silva; Zhikang Qian; Thomas Shenk; Dong Yu
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

5.  CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD.

Authors:  Michiel G H Betjes; Willem Weimar; Nicolle H R Litjens
Journal:  J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 10.121

6.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

7.  Fluorescence-based laser capture microscopy technology facilitates identification of critical in vivo cytomegalovirus transcriptional programs.

Authors:  Craig N Kreklywich; Patricia P Smith; Carmen Baca Jones; Anda Cornea; Susan L Orloff; Daniel N Streblow
Journal:  Methods Mol Biol       Date:  2014

Review 8.  Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.

Authors:  Anna C Hearps; Genevieve E Martin; Reena Rajasuriar; Suzanne M Crowe
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

Review 9.  'From immunosenescence to immune modulation': a re-appraisal of the role of cytomegalovirus as major regulator of human immune function.

Authors:  Paul Moss
Journal:  Med Microbiol Immunol       Date:  2019-05-03       Impact factor: 3.402

Review 10.  Cytomegalovirus and HIV: A Dangerous Pas de Deux.

Authors:  Sara Gianella; Scott Letendre
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.